Structural Origins for the Loss of Catalytic Activities of Bifunctional Human LTA4H Revealed through Molecular Dynamics Simulations
Open Access
- 25 July 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7) , e41063
Abstract
Human leukotriene A4 hydrolase (hLTA4H), which is the final and rate-limiting enzyme of arachidonic acid pathway, converts the unstable epoxide LTA4 to a proinflammatory lipid mediator LTB4 through its hydrolase function. The LTA4H is a bi-functional enzyme that also exhibits aminopeptidase activity with a preference over arginyl tripeptides. Various mutations including E271Q, R563A, and K565A have completely or partially abolished both the functions of this enzyme. The crystal structures with these mutations have not shown any structural changes to address the loss of functions. Molecular dynamics simulations of LTA4 and tripeptide complex structures with functional mutations were performed to investigate the structural and conformation changes that scripts the observed differences in catalytic functions. The observed protein-ligand hydrogen bonds and distances between the important catalytic components have correlated well with the experimental results. This study also confirms based on the structural observation that E271 is very important for both the functions as it holds the catalytic metal ion at its location for the catalysis and it also acts as N-terminal recognition residue during peptide binding. The comparison of binding modes of substrates revealed the structural changes explaining the importance of R563 and K565 residues and the required alignment of substrate at the active site. The results of this study provide valuable information to be utilized in designing potent hLTA4H inhibitors as anti-inflammatory agents.Keywords
This publication has 67 references indexed in Scilit:
- Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor DesignPLOS ONE, 2012
- Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment CrystallographyJournal of Medicinal Chemistry, 2009
- An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virusBiochemical and Biophysical Research Communications, 2008
- Analysis of ligand binding to proteins using molecular dynamics simulationsJournal of Theoretical Biology, 2008
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular SimulationJournal of Chemical Theory and Computation, 2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Leukotriene A4 hydrolaseProstaglandins & Other Lipid Mediators, 2002
- A Model of the Complex between Cyclin-Dependent Kinase 5 and the Activation Domain of Neuronal Cdk5 ActivatorBiochemical and Biophysical Research Communications, 1999
- Leukotriene A4 hydrolase is a zinc-containing aminopeptidaseBiochemical and Biophysical Research Communications, 1990